Step 8 of 10 · Decision support
Treatment plan
What this step shows
The recommended next treatment step, following statin → ezetimibe → PCSK9 inhibitor and taking intolerance and time on therapy into account.
Clinical pathway
Secondary Prevention
Risk category
Very High
LDL-C target
<1.4 mmol/L
Recommended next step
Add ezetimibe to the current statin therapy
Maximally tolerated statin therapy is in place but ezetimibe has not been added yet — add it before considering injectable therapy.
Current therapy on record
High-intensity statin · 3 month(s) on this regimen
Edit
How this was decided
- ✕ LDL-C already at target? 2 mmol/L vs. target <1.4 mmol/L.
- ✓ Currently on a statin? High-intensity statin.
- ✕ On ezetimibe? Ezetimibe not yet added.